Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 73124 CHICAGO, IL
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,101,372
+$535,622 QoQ
Shares Held
105,698
+14.9% QoQ
Ownership
0.349%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 95 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. RNAC ranks #270 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in RNAC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,101,372 105,698
2026-03-31 $565,750 91,992
2025-12-31 $627,362 87,013
2025-09-30 $932,972 91,289
2025-06-30 $861,787 82,944
2025-03-31 $1,217,001 92,337
2024-12-31 $1,701,987 95,030
2024-09-30 $1,017,413 63,115
2024-06-30 $835,256 30,924
2024-03-31 $608,051 935,464
2023-12-31 $651,576 945,685
2023-09-30 $1,004,173 947,334
2023-06-30 $1,045,207 933,221
2023-03-31 $289,735 208,443
2022-12-31 $241,250 213,496
2022-09-30 $350,133 213,496
2022-06-30 $260,419 198,794
2022-03-31 $960,136 780,599
2021-12-31 $2,689,498 825,000
2021-09-30 $3,515,676 845,115
2021-06-30 $2,541,133 607,927
2021-03-31 $3,319,010 733,483
2020-12-31 $2,420,666 798,900
2020-09-30 $2,001,839 807,194
2020-06-30 $442,647 155,862
2020-03-31 $199,578 82,813